Olema Pharmaceuticals, Inc. (OLMA)

27.46 -0.21 (-0.76%) USD  |  NASDAQ  |  Dec 24, 12:59
27.48 +0.02 (+0.07%) After-Hours: 13:59
More

Olema Pharmaceuticals SG&A Expense (TTM): 18.61M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for OLMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Replimune Group, Inc. 102.36M
Alnylam Pharmaceuticals, Inc. 1.181B
Insmed, Inc. 631.20M
Madrigal Pharmaceuticals, Inc. 715.08M